Protocols Seeing at Least 1 Patient in Previous 12
Months |
||
Investigator
|
Title
|
Category
|
Aberg
|
"AACTG A5197: A Phase II Double-Blind, Randomized, Placebo-Controlled Study to
|
A
|
Aberg
|
"AACTG A5216: A Randomized Phase II Study of the Safety, Immunologic and Virologic Effects of Cyclosporine A in Conjunction with Trizivir and Kaletra versus Trizivir and Kaletra Alone during Primary HIV-1 Infection"
|
A
|
Aberg
|
"ACTG A5175: A Phase IV, Prospective, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Individuals from Resource-Limited Settings (PEARLS) Trial"
|
A
|
Aberg
|
"ACTG A5209: A Pilot Study of the Safety, Efficacy, and Tolerability of Ezetimibe (ZETIA) in Combination with Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects"
|
A
|
Aberg
|
"ACTG A5229: A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy"
|
A
|
Aberg
|
ACTG 362: A Randomized, Placebo Controlled, Trial to Determine the Efficacy of Azithromycin Prophylaxis for the Primary Prevention of Mycobacterium Avium Complex (MAC) Disease and other Infections in Subjects who have Achieved an Increase in CD4 cells on Antiretroviral Therapy
|
A
|
Aberg
|
ACTG A5001: ACTG Longitudinal Linked Randomized Trials (ALLRT) Protocol
|
A
|
Aberg
|
ACTG A5068: A Randomized Phase I/II Pilot Study of Intermittent Withdrawal of Antiretroviral Therapy as an Immunization Strategy and Double-Blinded Immunization with ALVAC-HIV vCP1452 in Subjects with Persistent CD4+ Cell Counts Greater than 500 Cells/mm3 and Plasma HIV-1 RNA Levels <50 Copies/ml
|
A
|
Aberg
|
ACTG A5142: A Phase III, Randomized, Open-Label Comparision of Lopinavir/Ritonavir Plus Efavirenz Versus Lopinavir/Ritonavir Plus Stavudine Extended Release (or Zidovudine) Plus Lamivudine Versus Efavirenz Plus Stavudine Extended Release (or Zidovudine) Plus Lamivudine for the Initial Therapy of HIV-1 Infection
|
A
|
Aberg
|
ACTG A5164: A Phase IV Study of Antiretroviral Therapy for HIV-Infected Adults Presenting with Acute Opportunistic Infections: Immediate Versus Delayed Initiation
|
A
|
Aberg
|
ACTG A5178: Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)
|
A
|
Aberg
|
ACTG A5202: A Phase IIIB Randomized Trial of Open-Label Efavirenz or Atazanavir with Ritonavir in Combination with Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
|
A
|
Aberg
|
ACTG A5206: A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects
|
A
|
Aberg
|
ACTG A5211: Phase II, Randomized, Double-Blind Study of the Safety and Efficacy of SCH 417690 (an Orally Administered HIV-1 Entry Inhibitor) in HIV-Infected, Treatment-Experienced Subjects
|
A
|
Aberg
|
ACTG A5220: Improving Immune Response to Hepatitis B Vaccine in HIV-Positive Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a Vaccine Adjuvant: A Phase II Open-Label Pilot Study\
|
A
|
Aberg
|
ACTG A5223: Sex Differences in Lopinavir/Ritonavir Pharmacokinetics among HIV-1-Infected Men and Women
|
A
|
Abramson
|
Leukocyte Gene Expression in Osteoarthritis
|
A
|
Achkar
|
Immunodiagnostic Tests for the Rapid Diagnosis of TB
|
A
|
Axelrod
|
Phase 1 Pharmacokinetic Study of Kinetin in Carriers of the Familial Dysautonomia Mis-Splicing Mutation\
|
A
|
Ayappa
|
Relating Sleep Disordered Breathing to Daytime Function
|
|
Ayappa
|
Validation of Apnea Risk Evaluation Sleep Scoring
|
A
|
Banikazemi
|
"A Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients"
|
D
|
Becker
|
Determination of the Effect of Radio-Opaque Contrast Media (CM) on Renal Function by Glomerular Filtration Rate (GFR)
|
A
|
Becker
|
Gadolinium Nephrotoxicity: A Measurement of Glomerular Filtration Rate (GFR)
|
A
|
Belmont
|
Lipitor to Prevent Avascular Necrosis in Systemic Lupus Erythematosus
|
A
|
Bhardwaj
|
NYU 03-03: A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus QS-21 as Adjuvants to Stimulate Anti-tumor Immunity, and Baseline Immune Monitoring of Melanoma Patients
|
A
|
Bini
|
Assessment of Adrenal Function in Patients with Chronic Hepatitis C Virus Infection and Severe Fatigue
|
A
|
Blank
|
GOG-0199: Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal
|
A
|
Blank
|
NYU 02-30: A Phase I/II Study of OSI 774 in Combination with Carboplatin and Paclitaxel in Patients with Ovarian or
|
A
|
Blank
|
NYU 03-17: A Phase II Study of Oxaliplatin in Combination with Paclitaxel in Patients with Locally Recurrent or Metastatic Cervical Cancer
|
A
|
Borkowsky
|
"PACTG P1038: A Phase I/II Safety, Tolerability, and Pharmacokinetic Study of High Dose Lopinavir/Ritonavir With or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated with Protease Inhibitors"
|
A
|
Borkowsky
|
"PENPACT 1 (PENTA 9/PACTG 390): A
|
A
|
Borkowsky
|
A 48-Week, Phase II, Non-Comparative, Open-Label, Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir BID when Administered to HIV-1 Infected, PI-Naive and Experienced Pediatric Subjects, 2 to 18 Years Old and of GW433908 BID Administered to PI-Naive, Pediatric Subjects 2 to <6 Years Old
|
D
|
Borkowsky
|
ACTG 219 Pediatric Late Outcomes
|
A
|
Borkowsky
|
P1061s: Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV-Infected Children Treated with Highly Active Antiretroviral Therapy (HAART)
|
A
|
Borkowsky
|
PACTG 1020-A: Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and -Experienced HIV-Infected Infants, Children and Adolescents
|
A
|
Borkowsky
|
PACTG 1025: Perinatal Core Protocol
|
A
|
Borkowsky
|
PACTG P1006: The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children
|
A
|
Bosland
|
Prostate Cancer Chemoprevention Clinical Trials
|
A
|
Buyon
|
ACR Re-Classification of SLE Criteria (A ROSE)
|
A
|
Buyon
|
Predictors of Pregnancy Outcomes in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
|
A
|
Chinitz
|
Adenovirus as a Possible Etiology of Atrial Fibrillation
|
A
|
Clancy
|
"Circulating Endothelial Cells, a Biomarker to Predict Subclinical Atherosclerosis in Patients with SLE"
|
A
|
Clelland
|
Alzheimer's Diagnosis: Leukocyte Multigene Syndrome
|
A
|
Clelland
|
Schizophrenia Diagnosis: Leukocyte Multigene Signatures
|
A
|
Coffey
|
"A Double Blind, Placebo Controlled Trial of Aripiprazole in Children and Adolescents with Tourette's Disorder and Explosive Outbursts"
|
A
|
Coffey
|
Open Label Trial of Aripiprazole in Children and Adolescents with Tourette's Disorder
|
A
|
Coffey
|
Treatment of Adolescent Suicide
|
A
|
Condos
|
Aerosol Deposition and Cellular Response in Patients Receiving Aerosol Interferon-gamma for Idiopathic Pulmonary Fibrosis (IPF)
|
A
|
Condos
|
Prospective Evaluation Of Patients With Idiopathic Pulmonary Fibrosis Through An IPF Registry
|
A
|
Condos
|
Tuberculosis Research Blood Bank
|
A
|
Connolly
|
Quantifying Heart Failure Severity in Pediatric Patients
|
A
|
Convit
|
"Type 2 Diabetes in Adolescence, Cognition, and the Brain"
|
A
|
Convit
|
Brain in Diabetes: Response to Increased Metabolic Demand
|
A
|
Dasanayake
|
Periodontal Disease and Prematurity Protocol
|
A
|
Feit
|
Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)
|
A
|
Formenti
|
"Response, Resistance and Metastasis of Locally-Advanced Breast Cancer (LABC) in a Multi-Ethnic Cohort"
|
A
|
Formenti
|
NYU 00-05: Phase I Study of Bi-Weekly Taxol and Definitive Radiation in Androgen Ablated Locally Advanced Prostate Cancer
|
A
|
Formenti
|
NYU 01-16: Locally Advanced Breast Cancer: Individualized Treatment Based on Tumor Molecular Characteristics
|
A
|
Francois
|
The Role of Bacterial Colonization in the Development of Upper Gastrointestinal Pathology
|
A
|
Francois
|
The Role of Inflammatory Polymorphisms in Colorectal Neoplasia
|
A
|
Friedberg
|
Longitudinal Study of Ocular Complications of AIDS
|
A
|
Gabbay
|
"A Double-Blind, Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents with Tourette's Disorder"
|
A
|
Gabbay
|
Immune System Activation in Adolescent Suicide
|
A
|
Gabbay
|
Omega-3 Fatty Acids in Adolescents with Depression
|
A
|
Goldenberg
|
NYU 03-41: Bevacizumab (RhuMab-VEGF) in Hepatocellular Cancer for Patients wtih Unresectable Tumor (without invasion of the main portal vein or metastatic disease): A Phase II Study
|
A
|
Grant
|
Effect of Temporal Lobectomy on Sensory Deficits in Temporal Lobe Epilepsy (TLE)
|
A
|
Grossman
|
Quantitative MR Imaging and Proton Spectroscopy in Multiple Sclerosis
|
A
|
Hochster
|
"NYU 02-12: A Phase I and Pharmacokinetic Study of Oxaliplatin (Eloxatin) in
|
A
|
Hochster
|
ECOG N0147: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
|
A
|
Hochster
|
NYU 04-01: Phase I/II Dose-Escalating Study of Bi-Weekly ALIMTA and Fixed Dose
|
A
|
Johnson
|
Pulmonary Gas Flow Measurement Using [3]He MRI
|
A
|
Kleinberg
|
"A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults with Growth Hormone Deficiency [BRANY]"
|
D
|
Kleinberg
|
"Extension to a Multicenter, Randomized, Crossover, Open-Label, Dose-Finding Study to Compare the Safety, Efficacy and PK/PD Relationship of Multiple Doses of SOM230 (200 mcg, 44 mcg and 600 mcg bid) and Doses of Open-Label Sandostatin (100 mcg tid) in Acromegalic Patients"
|
D
|
Krieger
|
"Cellular Oxidative Stress, Serum NE and Periodic Breathing in CHF"
|
A
|
Krieger
|
Mechanisms of Endothelial Dysfunction in Sleep Apnea
|
A
|
Llinas
|
Functional Brain Imaging in Normal Aging
|
A
|
Llinas
|
Magnetoencephalographic Studies of Neurologic and Psychiatric Patients
|
A
|
McHugh
|
Development of a Mind-Body Center at NYU
|
A
|
Muggia
|
NYU 00-60: Cancer Screening and Prevention Project for High Risk Women
|
A
|
Muggia
|
NYU 04-26: Intraperitoneal (IP) Therapy with Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies
|
A
|
Muggia
|
NYU 99-55: A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined with Intravenous Cisplatin in Patients with Advanced Cancer of the Digestive System
|
A
|
Norman
|
Use of an Apnea Risk Evaluation System (ARES) for Diagnoses of Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
|
A
|
Novik
|
ECOG PACCT-1: Trial Assigning Individualized Options for Treatment (The TAILORx Trial)\
|
A
|
Novik
|
NSAPB-38: A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women
|
A
|
Oliver
|
Altered Dendritic Cell Function in
|
A
|
Oliver
|
T Cell Immunity in Collagen Biosynthesis of Scleroderma
|
A
|
Pena-Sing
|
FREEDOM Trial: Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease
|
A
|
Pillon
|
Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
|
D
|
Pollack
|
"Assessment of the Safety, Efficacy, Tolerability, and Pharmacokinetics of PEG-Intron Plus REBETOL in Pediatric Patients with Chronic Hepatitis C"
|
D
|
Pollack
|
A Phase 2, Randomized, Double-Blind Study Exploring the Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects Currently Being Treated with Adefovir Dipivoxil for Chronic Hepatitis B and Having Persistent Viral Replication\
|
D
|
Pollack
|
A Phase 3 Double Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to <18) with Chronic Hepatitis B [BRANY]
|
D
|
Pomara
|
A Multicenter, Randomized, 24-52 Week, double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Saredutant 100 mg Once Daily in the Prevention of Relapse of Depressive Symptoms in Outpatients with Major Depressive Disorder who Achieved an Initial Response to 12 Weeks of Open-Label Treatment with Saredutant 100 mg Once Daily\
|
D
|
Pomara
|
Long-Term Lorazepam Use and Acute Toxicity in the Elderly
|
A
|
Rapoport
|
Impact of CPAP on Functional Outcomes in Milder OSA
|
A
|
Reibman
|
Ambient Particulate Matter and Human Bronchial Epithelial Cells
|
A
|
Reibman
|
Blood-Derived Dendritic Cells and Epithelial Cells
|
A
|
Reibman
|
Bronchoalveolar Lavage and Brushings In Normal Volunteers
|
A
|
Reibman
|
Disease Modifying Genes in Severe Asthma
|
A
|
Reibman
|
NYU World Trade Center Responder
|
A
|
Reibman
|
Study of Acid Reflux Asthma (SARA)
|
A
|
Reisberg
|
Aging and Dementia Longitudinal Course of Subgroups
|
A
|
Ren
|
The Impact of Weight Loss after Bariatric Surgery on Esophageal Function and Sleep
|
A
|
Reynolds
|
Trial to Assess Chelation Therapy (TACT)
|
A
|
Rom
|
Host Response to TB and AIDS
|
A
|
Rom
|
NYU Biomarker Clinical and Epidemiologic Center
|
A
|
Rosenthal
|
Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
|
A
|
Rusinek
|
Alzheimer's Disease Neuroimaging Initiative
|
A
|
Ryan
|
"NYU 04-72: Neoadjuvant Therapy of Gastric Cancer with Irinotecan, Cisplatin, and Cetuximab Followed by Surgical Resection and Adjuvant Chemoradiation"
|
A
|
Ryan
|
NYU 03-64: A Phase I/II Study of Chemoradiation with Oxaliplatin and 5-FU for Locally
|
A
|
Smith
|
NYU 05-151: Study of the Effects of the Aromatase Inhibitor Letrozole in Postmenopausal Women at High Risk to Develop Breast Cancer
|
A
|
Valentine
|
The Development and Effect of HIV Specific CD4 Responses to Early Intervention in Primary HIV Infection Using Antiretroviral Therapy Alone or Antiretroviral Therapy with Vaccination
|
A
|
Volm
|
NYU 97-39: Temodal in Patients with Advanced Malignancies
|
A
|
Wan
|
"A Multicenter, Randomized, Double-Masked, Comparator Study of the Safety and
|
A
|
Wan
|
A Multicenter, Open-Label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150 Micrograms of Nestorone and 15 Micrograms of Ethinyl Estradiol\
|
A
|
Yazici
|
Hospital for Joint Diseases Arthritis Registry Monitoring Database (HJD-ARMD)
|
A
|
de Leon
|
Biomarkers in Early Alzheimer's Disease
|
A
|
de Leon
|
Clinical Correlates of Longitudinal PET
|
A
|
de Leon
|
Predictors of Cognitive Decline in Normal Aging
|
A
|